You are here

A Researcher from UCLouvain Co-Authors Groundbreaking Study on Parkinson’s Disease

Dr Emmanuelle Wilhelm © Erea Azurmendi
Dr Emmanuelle Wilhelm © Erea Azurmendi

With a dual background in medicine and neuroscience, Dr. Emmanuelle Wilhelm has been dedicated for several years to clinical and translational research projects focusing on movement disorders and neurostimulation. A physician and researcher affiliated with UCLouvain, she is currently undertaking a scientific stay at HM CINAC (Centro Integral de Neurociencias Abarca Campal) in Madrid, supported by a prestigious excellence grant awarded by Wallonia-Brussels International (WBI).

A Breakthrough in Understanding Parkinson’s Disease

Within this framework, she is among the co-authors of a study recently published in the renowned journal Movement Disorders. The research, led and supervised by Dr. Claudia Ammann and Dr. Guglielmo Foffani, investigates the link between altered excitability of the motor cortex and olfactory dysfunctions in patients with Parkinson’s disease. The identification of an association between motor and sensory circuit impairments suggests a shared pathogenic mechanism that may be active as early as the initial stages of the disease. These findings open new avenues for early diagnosis and more integrated therapeutic approaches to Parkinson’s disease.

A Significant Contribution from the Wallonia-Brussels Federation, Through WBI, to Neurological Research

The project was conducted at HM CINAC in Madrid, a world-renowned center for Parkinson’s disease research and treatment. Dr. Wilhelm’s contribution forms part of a broader research program related to her work on motor inhibition, brain stimulation, and early biomarkers of Parkinson’s disease.

This publication exemplifies the concrete impact of WBI’s excellence grants, which enable promising researchers to take part in cutting-edge international projects while strengthening the ties between the Wallonia-Brussels Federation and its partners abroad.

The support provided by Wallonia-Brussels International to emerging talents such as Dr. Wilhelm reflects the institution’s commitment to advanced medical research and its ambition to promote French-speaking scientific expertise within world-class international environments.

The article is available in open access via: https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.30171?campaign=wolearlyview

 

Linked articles